Previous studies found 90K overexpressed in GBM cell lines, and engineered enhancement of 90K expression caused tumor growth inhibition by stimulation of the residual cell-mediated immune defense in vivo [27]. This evidence concerns the gene LGALS3BP and glioblastoma.